Douglas Cunningham
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
Papers in
-
- HIV/AIDS drug development and treatment 7
- HIV/AIDS Research and Interventions 2
- Virology 2
- HIV Research and Treatment 2
- Co-authors
- Simiso Mandisa Sokhela (1 shared paper)David Bonner Richardson (1 shared paper)Sheetal Kassim (1 shared paper)Maria Reynolds (1 shared paper)Johannes Richard Bogner (1 shared paper)Hiroyuki Gatanaga (1 shared paper)William M. Valenti (1 shared paper)Pedro Enrique Cahn (1 shared paper)
- Journals
- The Lancet HIV (2 papers)The Lancet (2 papers)Antiviral Research (1 paper)Open Forum Infectious Diseases (1 paper)Clinical Infectious Diseases (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Douglas Cunningham
6 papers receiving 461 citations
Douglas Cunningham's Hit Papers
Peers
Comparison fields: 5 of 41
- Virology 146
- Infectious Diseases 376
- Emergency Medicine 85
- Hepatology 15
- Epidemiology 43
Countries citing papers authored by Douglas Cunningham
This map shows the geographic impact of Douglas Cunningham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Cunningham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Cunningham more than expected).
Fields of papers citing papers by Douglas Cunningham
This network shows the impact of papers produced by Douglas Cunningham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Cunningham. The network helps show where Douglas Cunningham may publish in the future.
Co-authors
The 20 scholars most cited alongside Douglas Cunningham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials Hit paper breakdown → | 2018 | 313 |
| 2 | 2017 | 99 | |
| 3 | 2019 | 33 | |
| 4 | 2023 | 17 | |
| 5 | 2025 | 7 | |
| 6 | 2023 | 4 | |
| 7 | 2026 | 0 |
About Douglas Cunningham
Douglas Cunningham is a scholar working on Infectious Diseases, Virology, Insect Science, Renewable Energy, Sustainability and the Environment and Obstetrics and Gynecology, having authored 7 papers that have together received 473 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), HIV/AIDS Research and Interventions (2 papers) and HIV Research and Treatment (2 papers). The work is most often cited by research in Virology (146 citations), Infectious Diseases (376 citations), Emergency Medicine (85 citations), Hepatology (15 citations) and Epidemiology (43 citations). Douglas Cunningham has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Simiso Mandisa Sokhela, David Bonner Richardson, Sheetal Kassim, Maria Reynolds, Johannes Richard Bogner, Hiroyuki Gatanaga, William M. Valenti, Pedro Enrique Cahn, Federico Hinestrosa and Stephanie Olsen Klopfer. Their work appears in journals such as The Lancet HIV, The Lancet, Antiviral Research, Open Forum Infectious Diseases and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.